|
Volumn 45, Issue 2, 2007, Pages 215-218
|
A clinical approach in regression of glomerulosclerosis.
a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ALDOSTERONE;
ANGIOTENSIN II;
ANGIOTENSIN RECEPTOR ANTAGONIST;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
PLASMINOGEN ACTIVATOR INHIBITOR 1;
ANIMAL;
DISEASE COURSE;
DISEASE MODEL;
FOCAL GLOMERULOSCLEROSIS;
HUMAN;
METABOLISM;
PATHOPHYSIOLOGY;
PHYSIOLOGY;
RAT;
RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;
REVIEW;
ALDOSTERONE;
ANGIOTENSIN II;
ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
ANIMALS;
DISEASE MODELS, ANIMAL;
DISEASE PROGRESSION;
GLOMERULOSCLEROSIS, FOCAL SEGMENTAL;
HUMANS;
PLASMINOGEN ACTIVATOR INHIBITOR 1;
RATS;
RENIN-ANGIOTENSIN SYSTEM;
|
EID: 42449145633
PISSN: 12204749
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (3)
|
References (15)
|